Published in Pharmacotherapy on January 01, 2009
Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. Br J Clin Pharmacol (2012) 1.26
Implementation of a clinical pharmacy education program in a teaching hospital: resident oriented documentation and intervention. Iran J Pharm Res (2010) 0.98
Health economic evaluation of the Lund Integrated Medicines Management Model (LIMM) in elderly patients admitted to hospital. BMJ Open (2013) 0.83
Impact of Clinical Pharmacist on the Pediatric Intensive Care Practice: An 11-Year Tertiary Center Experience. J Pediatr Pharmacol Ther (2015) 0.82
Psychiatric pharmacist integration into the medical home. Prim Care Companion CNS Disord (2013) 0.78
Should there be a cap on the number of patients under the care of a clinical pharmacist? Can J Hosp Pharm (2012) 0.75
The future role of pharmacists in primary care. Br J Gen Pract (2009) 0.75
Where does high-quality research in economic evaluation come from? Pharmacotherapy (2009) 0.75
Performance of a new speech translation device in translating verbal recommendations of medication action plans for patients with diabetes. J Diabetes Sci Technol (2012) 0.75
Cost analysis and cost-benefit analysis of a medication review with follow-up service in aged polypharmacy patients. Eur J Health Econ (2016) 0.75
American College of Clinical Pharmacy's vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice. Pharmacotherapy (2006) 9.72
ASHP guidelines on the pharmacy and therapeutics committee and the formulary system. Am J Health Syst Pharm (2008) 5.53
The definition of clinical pharmacy. Pharmacotherapy (2008) 4.47
Pure red-cell aplasia and epoetin therapy. N Engl J Med (2004) 3.49
Clinical pharmacist competencies. Pharmacotherapy (2008) 2.84
NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectives. J Natl Compr Canc Netw (2011) 2.73
Development of student professionalism. Pharmacotherapy (2009) 2.54
Recommended education for pharmacists as competitive clinical scientists. Pharmacotherapy (2009) 2.31
The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol (2004) 2.30
The Research on Adverse Drug Events and Reports (RADAR) project. JAMA (2005) 2.08
Cost-effectiveness of oral phenytoin, intravenous phenytoin, and intravenous fosphenytoin in the emergency department. Ann Emerg Med (2004) 2.04
Value on the margin? Am J Health Syst Pharm (2002) 2.01
National survey of the impact of drug shortages in acute care hospitals. Am J Health Syst Pharm (2004) 1.92
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process. Curr Drug Metab (2014) 1.88
Standards of practice for clinical pharmacists. Pharmacotherapy (2014) 1.87
Development and implementation of a pharmacist-managed clinical pharmacogenetics service. Am J Health Syst Pharm (2011) 1.85
Development and use of active clinical decision support for preemptive pharmacogenomics. J Am Med Inform Assoc (2013) 1.80
Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med (2009) 1.79
Healthy People 2010: challenges, opportunities, and a call to action for America's pharmacists. Pharmacotherapy (2004) 1.71
Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy (2003) 1.64
The research agenda of the American College of Clinical Pharmacy. Pharmacotherapy (2007) 1.61
Prioritizing future research on off-label prescribing: results of a quantitative evaluation. Pharmacotherapy (2008) 1.58
Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. Annu Rev Pharmacol Toxicol (2014) 1.58
The incident user design in comparative effectiveness research. Pharmacoepidemiol Drug Saf (2012) 1.56
Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project. J Clin Oncol (2003) 1.50
PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics. Am J Med Genet C Semin Med Genet (2014) 1.49
Collaborative drug therapy management by pharmacists--2003. Pharmacotherapy (2003) 1.48
Guidelines for acute decompensated heart failure treatment. Ann Pharmacother (2004) 1.46
Projecting future drug expenditures--2004. Am J Health Syst Pharm (2004) 1.45
Increasing frequency of opioid prescriptions for chronic abdominal pain in US outpatient clinics. Clin Gastroenterol Hepatol (2011) 1.44
Medication therapy management services: definitions and outcomes. Drugs (2009) 1.44
Association between hospital size and pharmacy department productivity. Am J Health Syst Pharm (2007) 1.43
White paper on pharmacy technicians (2002): needed changes can no longer wait. J Am Pharm Assoc (Wash) (2003) 1.43
National survey on the effect of oncology drug shortages on cancer care. Am J Health Syst Pharm (2013) 1.43
Clinical implications of an accurate problem list on heart failure treatment. J Gen Intern Med (2005) 1.38
Projecting future drug expenditures--2012. Am J Health Syst Pharm (2012) 1.37
Biosimilars: Implications for health-system pharmacists. Am J Health Syst Pharm (2013) 1.36
The essential research curriculum for doctor of pharmacy degree programs. Pharmacotherapy (2010) 1.34
Comparison friction: experimental evidence from medicare drug plans. Q J Econ (2012) 1.33
Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how you count matters. COPD (2010) 1.29
Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans. J Clin Oncol (2005) 1.27
Tenets of professionalism for pharmacy students. Pharmacotherapy (2009) 1.22
Guidelines for therapeutic interchange-2004. Pharmacotherapy (2005) 1.21
ACCP white paper: Essential components of a faculty development program for pharmacy practice faculty. Pharmacotherapy (2009) 1.16
Examination of state-level changes in the pharmacist labor market using Census data. J Am Pharm Assoc (2003) (2007) 1.16
Projecting future drug expenditures: 2011. Am J Health Syst Pharm (2011) 1.16
Evaluation and justification of clinical pharmacy services. Expert Rev Pharmacoecon Outcomes Res (2009) 1.12
Cultural competence in health care and its implications for pharmacy. Part 1. Overview of key concepts in multicultural health care. Pharmacotherapy (2007) 1.11
Global survey of hospital pharmacy practice. Am J Health Syst Pharm (2009) 1.11
Ambulatory care for constipation in the United States, 1993-2004. Am J Gastroenterol (2008) 1.07
Medicare Part D and quality of prescription medication use in older adults. Drugs Aging (2011) 1.05
Collaborative drug therapy management and comprehensive medication management-2015. Pharmacotherapy (2015) 1.04
Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Arch Intern Med (2009) 1.04
Drug errors and related interventions reported by United States clinical pharmacists: the American College of Clinical Pharmacy practice-based research network medication error detection, amelioration and prevention study. Pharmacotherapy (2013) 1.04
Projecting future drug expenditures in U.S. nonfederal hospitals and clinics--2013. Am J Health Syst Pharm (2013) 1.02
Monitoring of pharmacy staffing, workload, and productivity in community hospitals. Am J Health Syst Pharm (2006) 1.02
Factors influencing decisions regarding influenza vaccination and treatment: a survey of healthcare workers. Infect Control Hosp Epidemiol (2002) 1.02
Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patients. Cancer (2012) 0.99
Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption. Pharmacotherapy (2011) 0.99
Economic evaluations of clinical pharmacy services: 2006-2010. Pharmacotherapy (2014) 0.98
Postgraduate year one pharmacy residency program equivalency. Pharmacotherapy (2009) 0.97
National trends in prescription drug expenditures and projections for 2014. Am J Health Syst Pharm (2014) 0.95
Projecting future drug expenditures--2008. Am J Health Syst Pharm (2008) 0.93
NCCN Oncology Risk Evaluation and Mitigation Strategies White Paper: Recommendations for Stakeholders. J Natl Compr Canc Netw (2010) 0.92
Projecting future drug expenditures--2009. Am J Health Syst Pharm (2009) 0.92
Assessing Anticoagulation Practice Patterns in Patients on Durable Mechanical Circulatory Support Devices: An International Survey. ASAIO J (2015) 0.92
Thalidomide-associated deep vein thrombosis and pulmonary embolism. Am J Med (2002) 0.91
The clinical utility of lenalidomide in multiple myeloma and myelodysplastic syndromes. J Oncol Pharm Pract (2009) 0.91
Pharmacy-based bone mass measurement to assess osteoporosis risk. Ann Pharmacother (2002) 0.91
Clinical and economic value of screening for Kras mutations as predictors of response to epidermal growth factor receptor inhibitors. Am J Health Syst Pharm (2009) 0.91
Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting. Pharmacotherapy (2008) 0.90
Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease. Pharmacotherapy (2009) 0.89
Projecting future drug expenditures--2006. Am J Health Syst Pharm (2006) 0.89
A first step towards translating evidence into practice: heart failure in a community practice-based research network. Inform Prim Care (2004) 0.88
Measuring hospital efficiency with Data Envelopment Analysis: nonsubstitutable vs. substitutable inputs and outputs. J Med Syst (2009) 0.88
Caveat medicus: consequences of federal investigations of marketing activities of pharmaceutical suppliers of prostate cancer drugs. J Clin Oncol (2005) 0.87
Projecting future drug expenditures--2007. Am J Health Syst Pharm (2007) 0.87
Rewards and advancements for clinical pharmacists. Pharmacotherapy (2010) 0.87
Stability of cetuximab and panitumumab in glass vials and polyvinyl chloride bags. Am J Health Syst Pharm (2010) 0.86
Retracted publications in the drug literature. Pharmacotherapy (2012) 0.86
Efficacy and safety of cefepime in pediatric patients: a systematic review and meta-analysis. J Pediatr (2010) 0.86
Utilization of the Center for the Advancement of Pharmaceutical Education Educational Outcomes, revised version 2004: report of the 2005 American College of Clinical Pharmacy Educational Affairs Committee. Pharmacotherapy (2006) 0.86
Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population. Clin Ther (2004) 0.85